ProShares Ultra NASDAQ Biotechnology
21 hedge funds and large institutions have $5.9M invested in ProShares Ultra NASDAQ Biotechnology in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 7 closing their positions.
Holders
21
Holders Change
-4
Holders Change %
-16%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
7
Closed
7
Calls
$849K
Puts
$1.52M
Net Calls
-$672K
Net Calls Change
-$859K